 |
| LOGIN REGISTER |
This medication is a gadolinium based contrast agent, prescribed for visualization of brain along with magnetic resonance imaging (MRI).
Contraindicated in patients with hypersensitivity.
IV- The recommended dose is 0.2 mL/kg, (0.1 mmol/kg) as bolus injection.
It comes as a powder for injection (diluted with fluid) to be administered by a healthcare provider into the vein.
• Caution should be exercised in patients with history of acute kidney injury, impaired elimination of GBCAs, any allergy, who are taking other medications.
• Patient with impaired elimination of GBCAs may experience with increased risk of Nephrogenic Systemic Fibrosis.
• Monitor patients closely for need of emergency breathing support.
• Most frequent: Nausea, headache, injection site pain, injection site coldness and burning sensation.
• Heart: Abnormal heart rhythm, fast or slow heart rate.
• Immune System: Hypersensitivity/anaphylactoid reactions including heart arrest, respiratory arrest, blue or purple coloration of the skin or mucous, throat swelling, asthma, eye inflammation, eyelid swelling, increased tears, increased sweating and hives.
• Central Nervous System: Coma, convulsion, fainting, lightheadedness, smell loss, tremor
• Musculoskeletal: Muscle contracture, muscle weakness.
• Gastrointestinal: Diarrhea, increased salivary secretion.
• General: Uneasiness and fever.
• Skin: Inflammation of a vein
Avoid excess dosage.
Store it at controlled room temperature (25°C).
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer
© All Rights Reserved 1997 - 2022
This site complies with the HONcode standard for trustworthy health information: verify here.
